Navigation Links
Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
Date:9/13/2007

- New assay assures integrity of RNA samples; offers improved throughput

and walk-away time -

HOPKINTON, Mass., Sept. 13 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP) today launched a new high throughput RNA assay for automatically assessing the concentration, integrity and overall quality of purified RNA samples. The assay, which was expected by the research community, was launched on schedule and runs in a microfluidic chip format on Caliper's LabChip 90 instrument and has been designed specifically so that researchers can conveniently analyze larger numbers of samples rapidly. The new assay measures the integrity of purified RNA samples prior to using such samples for critical applications such as microarray analysis or quantitative transcript analysis using real-time PCR. In combination with the LabChip 90 instrument and high throughput analysis software, the new HT RNA assay provides full walk away automation for up to 300 samples per day, resulting in significant time and cost savings when carrying out high throughput gene expression studies.

"Gene expression analysis has become a key tool for new target identification, lead optimization, and even for toxicological profiling," said Kevin Hrusovsky, President and CEO, Caliper Life Sciences. "The new HT RNA assay, which compliments our existing LC 90 DNA and protein assays, will allow researchers to produce a larger amount of significantly higher quality gene expression data. This new product release reflects our strategy of providing tools and services to enable new experimental approaches that can directly accelerate the development and advancement of new drug discovery targets as well as help move candidate compounds from hits to validated leads."

Caliper's high throughput RNA assay allows for a once-a-day setup with walk up service throughout the day, ensuring ease-of-use for bench scientists as they complete this critical part of their workload. The assay is extremely time-efficient and cost-sensitive, automating RNA quality assessment, reducing manual pipetting and providing sample integrity assessment results in 80 seconds per sample. The microfluidic processing also uses only 2ul of sample, which reserves most of the valuable sample for use in processes further downstream.

About Caliper Life Sciences

Caliper Life Sciences is a leading provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com.

Caliper and LabChip are registered trademarks of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Automation of the Eppendorf Perfectprep BAC 96 DNA Kit on the Caliper Life Sciences Sciclone ALH 3000
2. Perscitus Biosciences secures $250K Commerce loan
3. Wisconsin biosciences rise to the challenge
4. Wisconsin professors elected to National Academy of Sciences
5. Quintessence Biosciences advances cancer drug
6. Quintessence Biosciences names new president
7. InvivoSciences receives NIH grant for heart technology
8. Caden Biosciences may signal critical mass
9. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
10. QBI Life Sciences snags $130,000 NIH grant
11. WARF signs licensing pact with BD Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Eurofins announces the appointment of Sean Murray ... Scientific Inc. (ESI). Mr. Murray will bring valuable ... entrepreneurial experience in leading international business teams. As the National Division ... to uphold Eurofins, status as the global leader in bio-analytical testing ... , , ...
(Date:12/8/2016)... Oxford Gene Technology (OGT), The Molecular ... with the launch of the SureSeq myPanel™ NGS Custom FH ... familial hypercholesterolemia (FH). The panel delivers single nucleotide variation (SNV) ... panel and allows customisation by ,mix and match, of fully-optimised ... LDLR , P C SK9 , ...
(Date:12/8/2016)... ... December 08, 2016 , ... Microbial genomics leader, uBiome, ... is one of just six company finalists in the Health & Medicine category. ... companies nominated as finalists in this year’s awards include Google, SpaceX, Oculus, and ...
(Date:12/8/2016)... , Dec. 8, 2016  HedgePath Pharmaceuticals, ... that discovers, develops and plans to commercialize innovative ... shares of common stock were approved for trading ... begin trading on the OTCQX, effective today, under ... for the OTCQX market, companies must meet high ...
Breaking Biology Technology:
(Date:12/7/2016)... 7, 2016 BioCatch , the global leader ... patent portfolio, which grew to over 40 granted and pending patents. ... , , ... entitled " System, Device, and Method Estimating Force Applied to ... makers to forego costly hardware components needed to estimate the force and ...
(Date:12/6/2016)... Valencell , the leading innovator in performance biometric ... consecutive year of triple digit growth for its PerformTek ... 360 percent increase in companies who have acquired Valencell ... sales of its wrist and ear Benchmark™ sensor systems, ... hearables for fitness and healthcare applications. ...
(Date:12/2/2016)... , Dec. 1, 2016   SoftServe , ... BioLock , an electrocardiogram (ECG) biosensor analysis ... a key IoT asset. The smart system ensures ... vehicle,s steering wheel and mobile devices to easily ... As vehicle technology advances, so too ...
Breaking Biology News(10 mins):